title: [The cost of Mohs micrographic surgery for basal cell carcinoma. The Ambroise Paré hospital's experience (Boulogne, France)].
abstract: OBJECTIVE
  Mohs'micrographic surgery is generally considered as the best procedure for the treatment of difficult basal cell carcinomas. It is supposed to be costly, but an economic evaluation, with a cost-outcome analysis, is necessary to estimate the actual contribution of this procedure in skin cancer treatment, in comparison with the reference procedure, i.e. traditional surgical excision. Our aim was to evaluate the actual cost of Mohs'surgery applied on basal cell carcinoma treatment in France.
  
  
  METHODS
  The charts of 97 patients treated by Mohs'surgery between january 1997 and july 2001 in a teaching hospital near Paris (Ambroise Paré hospital, Boulogne), where Mohs'surgery is exclusively performed in France, were reviewed. Direct costs were derived from resource utilization of staff and material required for Mohs'surgery, estimated by a micro-costing method. Indirect costs and total costs were then calculated.
  
  
  RESULTS
  When adding surgery and pathology facility costs, mean direct and total costs per basal cell carcinoma were 776.0 (range: 538.4-1273.9), and 1014.6 Euros (range: 777-1512.4), respectively. When including costs of diagnosis, the average total cost per procedure was 1084.3 Euros.
  
  
  CONCLUSIONS
  These costs appear higher than those obtained with other methods of valuation of hospital costs used in France, but they are slightly lower than those found in the literature. The next stage will be to estimate, in the same way, the cost of traditional surgical excision for the same type of lesions, and to calculate the incremental cost-effectiveness ratio between the two procedures, with rate of recurrence at five years as the effectiveness outcome.
authors.affiliation: Service de Santé Publique et d'Information Médicale, Hôpital Ambroise Paré, Assistance Publique-hôpitaux de Paris, Université de Versailles Saint Quentin en Yvelines, Boulogne.
authors.forename: M
authors.initials: M
authors.lastname: Sznajder
authors.forename: V
authors.initials: V
authors.lastname: Chaussade
authors.forename: U
authors.initials: U
authors.lastname: Zimmermann
authors.forename: J-F
authors.initials: JF
authors.lastname: Sei
authors.forename: N
authors.initials: N
authors.lastname: Bendersky
authors.forename: B
authors.initials: B
authors.lastname: Franc
authors.forename: P
authors.initials: P
authors.lastname: Saiag
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002280:Basal Cell Carcinoma / Q000191:economics* / Q000601:surgery*; D003365:Costs and Cost Analysis; D005260:Female; D005602:France; D006761:Hospitals; D006801:Humans; D008297:Male; D008875:Middle Aged; D015580:Mohs Surgery / Q000191:economics*; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000191:economics* / Q000601:surgery*